# Aquestive Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/aquestive-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 28 | | Claims under review | 1 | | Evidence records | 12 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:20.15485+00:00 | | Last reviewed | 2026-10-17T04:46:20.15485+00:00 | ## Identity - Legal name: Aquestive Therapeutics, Inc. - Display name: Aquestive Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T07:13:12.584373+00:00 | | Completeness | 0.409 | | Record Quality | 0.803 | | Directors | 10 | | Committees | 3 | | Governance events | 9 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Abigail L. Jenkins: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:5 - Daniel Barber: Director. Status: current. Independent: false. Since: 2022-01-01. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:6 - Gregory B. Brown, M.D.: Director. Status: current. Independent: true. Since: 2007-01-01. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:7 - John S. Cochran: Director. Status: current. Independent: true. Since: 2004-01-01. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:8 - Julie Krop, M.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:9 - Marco Taglietti, M.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:10 - Timothy E. Morris: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:11 - Abigail L. Jenkins: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_record:26 - John S. Cochran: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Compensation (chair); Nominating and Governance (member). claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_record:23 - Timothy E. Morris: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Audit (chair); Compensation (member). claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_record:21 ## Committees - Audit (audit). Chair: Timothy E. Morris. Members: Timothy E. Morris (chair, current). committee_id=alpha:committee:aquestive-therapeutics-inc:audit - Compensation (compensation). Chair: John S. Cochran. Members: John S. Cochran (chair, current); Timothy E. Morris (member, current). committee_id=alpha:committee:aquestive-therapeutics-inc:compensation - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Abigail L. Jenkins (member, current); John S. Cochran (member, current). committee_id=alpha:committee:aquestive-therapeutics-inc:nominating-and-governance ## Executive leadership - Daniel Barber: Named Executive Officer / Director. Status: current. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:16 - Lori J. Braender: Named Executive Officer. Status: current. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:17 - A. Ernest Toth, Jr.: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:12 - A. Mark Schobel: Chief Innovation and Technology Officer. Status: unknown. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:13 - Carl N. Kraus: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:14 - Cassie Jung: Chief Operating Officer [COO]. Status: unknown. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:15 - Melina T. Cioffi: Senior Vice President Regulatory Affairs. Status: unknown. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:18 - Peter Boyd: Senior Vice President Information Technology, Human Resources and Communications. Status: unknown. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:19 - Sherry Korczynski: Senior Vice President Sales and Marketing. Status: unknown. claim_id=alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:20 ## Governance events - EXECUTIVE_APPOINTED: Daniel Barber executive of Aquestive Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:10040wq1omjfno - EXECUTIVE_APPOINTED: Lori J. Braender executive of Aquestive Therapeutics, Inc., effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:1c1o2nu13s99fk - DIRECTOR_APPOINTED: Abigail L. Jenkins seat on Aquestive Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:1wyazl81phjfbg - DIRECTOR_APPOINTED: Daniel Barber seat on Aquestive Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:2h7dvz1q4zobp - DIRECTOR_APPOINTED: Timothy E. Morris seat on Aquestive Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:f714813icip7 - DIRECTOR_APPOINTED: Julie Krop, M.D. seat on Aquestive Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:1gax0fj1qoozzl - DIRECTOR_APPOINTED: Marco Taglietti, M.D. seat on Aquestive Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:1liypuber94cp - DIRECTOR_APPOINTED: Gregory B. Brown, M.D. seat on Aquestive Therapeutics, Inc., effective 2007-01-01. Effective: 2007-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:14k9bwt1qy5scj - DIRECTOR_APPOINTED: John S. Cochran seat on Aquestive Therapeutics, Inc., effective 2004-01-01. Effective: 2004-01-01. Detected: 2026-10-17T04:46:20.15485+00:00. event_id=alpha:event:transition:1hhcgqz2ihqb7 ## Scoped resources - `alpha://company/aquestive-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record - `alpha://company/aquestive-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=identity - `alpha://company/aquestive-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/aquestive-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=board - `alpha://company/aquestive-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=committees - `alpha://company/aquestive-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=leadership - `alpha://company/aquestive-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=ownership - `alpha://company/aquestive-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=financials - `alpha://company/aquestive-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/aquestive-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=compensation - `alpha://company/aquestive-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=governance - `alpha://company/aquestive-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/aquestive-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=audit - `alpha://company/aquestive-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=legal - `alpha://company/aquestive-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=risk - `alpha://company/aquestive-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=cyber - `alpha://company/aquestive-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/aquestive-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=agents - `alpha://company/aquestive-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/aquestive-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=events - `alpha://company/aquestive-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=relationships - `alpha://company/aquestive-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=assessments - `alpha://company/aquestive-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:timothy-e-morris","name":"Timothy E. Morris"},"source_id":"board_seats"}` - Claim alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:john-s-cochran","name":"John S. Cochran"},"source_id":"board_seats"}` - Claim alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:timothy-e-morris","name":"Timothy E. Morris"},"source_id":"board_seats"}` - Claim alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:abigail-l-jenkins","name":"Abigail L. Jenkins"},"source_id":"board_seats"}` - Claim alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:john-s-cochran","name":"John S. Cochran"},"source_id":"board_seats"}` ## Leadership - Abigail L. Jenkins: Director. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:5. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2. - Daniel Barber: Director. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:6. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2. - Gregory B. Brown, M.D.: Director. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:7. Valid from: 2007-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2. - John S. Cochran: Director. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:8. Valid from: 2004-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2. - Julie Krop, M.D.: Director. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2. - Marco Taglietti, M.D.: Director. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:10. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2. - Timothy E. Morris: Director. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:11. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2. - A. Ernest Toth, Jr.: Chief Financial Officer. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c8f1c37dd7f28698c4b254e6637ce0ec36b8fd96b0af2280b7c10ccf27a47d90. - A. Mark Schobel: Chief Innovation and Technology Officer. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:951364c33c6fb59f6ab9a16eeedc8d96fd3335f25ef1cd3cf921031106d95a68. - Carl N. Kraus: Chief Medical Officer. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8fa1192b79edde28344c6b7a65d334bb10607df1271f368fb9e9ebc6fc0dd53d. - Cassie Jung: Chief Operating Officer. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:79cd2411481c434c1f3566ec997f7355218d78db51b26824e6c28e31bf45d631. - Daniel Barber: Named Executive Officer / Director. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:16. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:15007dd9948dc30d789bc5a55c866cca9e7317a28ad39d450f0a48d72f7e4e94. - Lori J. Braender: Named Executive Officer. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:17. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f182ffbde60d7023a765bcda9259b93b35edc8d15212110466b39bb8a380c440. - Melina T. Cioffi: Senior Vice President Regulatory Affairs. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:776345811e9dce0ddf0c08271d1e48f5d342ec177e0c60797a6200fa24754801. - Peter Boyd: Senior Vice President Information Technology, Human Resources and Communications. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5422aa102ab303bae4074fbd52bb640ba938dc2df1ebba4bfe9d3cace923a3fa. - Sherry Korczynski: Senior Vice President Sales and Marketing. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:49d9b3afc57d0a2177e5be3906988657807d5d27e4f108e9296fab29b45eb61f. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Timothy E. Morris; Members Timothy E. Morris (Chair). Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:80baeb9244a1ea905454bc5a1de4c507da2c9d962dcbd126b6dfff448cbc0106. - Compensation: Chair John S. Cochran; Members John S. Cochran (Chair); Timothy E. Morris. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:80baeb9244a1ea905454bc5a1de4c507da2c9d962dcbd126b6dfff448cbc0106. - Nominating and Governance: Chair not stated; Members Abigail L. Jenkins; John S. Cochran. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_record:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:80baeb9244a1ea905454bc5a1de4c507da2c9d962dcbd126b6dfff448cbc0106. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Aquestive Therapeutics, Inc.. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:96b6cca2474128cc50d259775ef6e75e3276d8311929d9622031be0f5f0ba881. ## Entity Status - Public listing published. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:96b6cca2474128cc50d259775ef6e75e3276d8311929d9622031be0f5f0ba881. ## Published Fact - US. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:96b6cca2474128cc50d259775ef6e75e3276d8311929d9622031be0f5f0ba881. ## Committee Appointment - Timothy E. Morris: chair, Audit. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:80baeb9244a1ea905454bc5a1de4c507da2c9d962dcbd126b6dfff448cbc0106. - John S. Cochran: chair, Compensation. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:80baeb9244a1ea905454bc5a1de4c507da2c9d962dcbd126b6dfff448cbc0106. - Timothy E. Morris: member, Compensation. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:80baeb9244a1ea905454bc5a1de4c507da2c9d962dcbd126b6dfff448cbc0106. - Abigail L. Jenkins: member, Nominating and Governance. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:80baeb9244a1ea905454bc5a1de4c507da2c9d962dcbd126b6dfff448cbc0106. - John S. Cochran: member, Nominating and Governance. Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:80baeb9244a1ea905454bc5a1de4c507da2c9d962dcbd126b6dfff448cbc0106. ## Security Listing - AQST (NASDAQ). Claim: alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:security_listing:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:96b6cca2474128cc50d259775ef6e75e3276d8311929d9622031be0f5f0ba881. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:96b6cca2474128cc50d259775ef6e75e3276d8311929d9622031be0f5f0ba881: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/aquestive-therapeutics-inc). - alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2: [Aquestive Therapeutics, Inc. DEF 14A 2025-04-25](https://www.sec.gov/Archives/edgar/data/1398733/000114036125015781/ny20043036x1_def14a.htm). - alpha:projection-evidence:document:c8f1c37dd7f28698c4b254e6637ce0ec36b8fd96b0af2280b7c10ccf27a47d90: AQST executive roster source. - alpha:projection-evidence:document:951364c33c6fb59f6ab9a16eeedc8d96fd3335f25ef1cd3cf921031106d95a68: AQST executive roster source. - alpha:projection-evidence:document:8fa1192b79edde28344c6b7a65d334bb10607df1271f368fb9e9ebc6fc0dd53d: AQST executive roster source. - alpha:projection-evidence:document:79cd2411481c434c1f3566ec997f7355218d78db51b26824e6c28e31bf45d631: AQST executive roster source. - alpha:projection-evidence:document:15007dd9948dc30d789bc5a55c866cca9e7317a28ad39d450f0a48d72f7e4e94: [AQST DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1398733/000114036126016757/ny20064249x1_def14a.htm). - alpha:projection-evidence:document:f182ffbde60d7023a765bcda9259b93b35edc8d15212110466b39bb8a380c440: [AQST DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1398733/000114036126016757/ny20064249x1_def14a.htm). - alpha:projection-evidence:document:776345811e9dce0ddf0c08271d1e48f5d342ec177e0c60797a6200fa24754801: AQST executive roster source. - alpha:projection-evidence:document:5422aa102ab303bae4074fbd52bb640ba938dc2df1ebba4bfe9d3cace923a3fa: AQST executive roster source. - alpha:projection-evidence:document:49d9b3afc57d0a2177e5be3906988657807d5d27e4f108e9296fab29b45eb61f: AQST executive roster source. - alpha:projection-evidence:80baeb9244a1ea905454bc5a1de4c507da2c9d962dcbd126b6dfff448cbc0106: [Audit](https://www.sec.gov/Archives/edgar/data/1398733/000114036125015781/ny20043036x1_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/aquestive-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/aquestive-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/aquestive-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T07:13:12.356512+00:00; recorded 2026-10-17T07:13:12.356512+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.